Company: MBIO
Filing Date: 2025-01-15
Form Type: S-1
Source: 0001410578-25-000028
Chunk: 279

Company: MUSTANG BIO, INC.
Filing Date: 2025-01-15
Form: S-1
Chunk 279
---
                                   | ​ | ​    |         1,757 | ​ | ​    |          739 | ​ |
| Total accounts payable and accrued expenses | ​ | $    |        12,061 | ​ | $    |       14,017 | ​ |

Other includes approximately $ million of accrued consideration for the uBriGene Asset Purchase Agreement, see Note 5.

F-41

Note 8 – Notes Payable

On April 11, 2023, the Company’s long-term debt facility (the “Term Loan”) with Runway Growth Finance Corp. (“Runway”), originally entered into on March 4, 2023, was terminated upon receipt by Runway of a payoff amount of $ million from the Company comprised of principal, interest and the applicable final payment amount. The loss on extinguishment was recorded in interest expense in the Unaudited Statements of Operations. For the nine months ended September 30, 2024, and 2023, the Company recorded the following components in interest expense:

| ​                             
 ​                             
 ($ in thousands)              | ​ 
 ​ | ​                                       
 For the nine months ended September 30, 
 2024                                    | ​ | ​ | ​    
 2023 |     ​ |
|:------------------------------|:--|:----------------------------------------|--:|:--|:-----|------:|
| Interest expense              | ​ | $                                       | — | ​ | $    | 1,187 |
| Amortization of Debt Discount | ​ | ​                                       | — | ​ | ​    |   118 |
| Loss on Extinguishment        | ​ | ​                                       | — | ​ | ​    | 2,796 |
| Other                         | ​ | ​                                       | 4 | ​ | ​    |    11 |
| Total Interest Expense        | ​ | $                                       | 4 | ​ | $    | 4,112 |

Note 9 - Stockholders’ Equity Registration Statements On April 23, 2021, the Company filed a shelf registration statement on Form S-3 (File No. 333-255476) (the “2021 S-3”), which was declared effective on May 24, 2021. Under the 2021 S-3, the Company was able to sell up to a total of $ 200.0million of its securities. The 2021 S-3 expired on May 24, 2024. The Company sold approximately $